Brian J McMahon

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. ncbi request reprint Epidemiology and natural history of hepatitis B
    Brian J McMahon
    Liver Disease and Hepatitis Program, Alaska Native Medical Center, Anchorage, Alaska, USA
    Semin Liver Dis 25:3-8. 2005
  2. ncbi request reprint The natural history of chronic hepatitis B virus infection
    Brian J McMahon
    Viral Hepatitis Program, Alaska Native Medical Center, Anchorage, Alaska 99508 5902, USA
    Semin Liver Dis 24:17-21. 2004
  3. ncbi request reprint Reinfection after successful eradication of Helicobacter pylori: a 2-year prospective study in Alaska Natives
    B J McMahon
    Department of Internal Medicine, Alaska Native Medical Center, Anchorage, USA
    Aliment Pharmacol Ther 23:1215-23. 2006
  4. ncbi request reprint Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study
    B J McMahon
    Departments of Internal Medicine and Surgery, Alaska Native Medical Center, Indian Health Service, Public Health Service, U S Department of Health and Human Services, Anchorage, Alaska, USA
    Hepatology 32:842-6. 2000
  5. ncbi request reprint Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up
    Brian J McMahon
    Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, and the Alaska Native Medical Center, Anchorage, Alaska 99508, USA
    Ann Intern Med 142:333-41. 2005
  6. pmc The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B
    Brian J McMahon
    Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium and Arctic Investigations Program, Centers for Disease Control and Prevention, 4315 Diplomacy Drive, Anchorage, AK, 99508, USA
    Hepatol Int 3:334-42. 2009
  7. doi request reprint The natural history of chronic hepatitis B virus infection
    Brian J McMahon
    Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, AK 99508, USA
    Hepatology 49:S45-55. 2009
  8. doi request reprint Implementing evidenced-based practice guidelines for the management of chronic hepatitis B virus infection
    Brian J McMahon
    Liver Disease and Hepatitis Program, Alaska Native Medical Center, Anchorage, Alaska 99508, USA
    Am J Med 121:S45-52. 2008
  9. pmc Natural history of chronic hepatitis B - clinical implications
    Brian J McMahon
    Liver Disease and Hepatitis Program, Alaska Native Medical Center, Anchorage, Alaska, USA
    Medscape J Med 10:91. 2008
  10. ncbi request reprint Viral hepatitis in the Arctic
    Brian J McMahon
    Viral Hepatitis Program, Alaska Native Medical Center Anchorage, Alaska 99508, USA
    Int J Circumpolar Health 63:41-8. 2004

Collaborators

Detail Information

Publications64

  1. ncbi request reprint Epidemiology and natural history of hepatitis B
    Brian J McMahon
    Liver Disease and Hepatitis Program, Alaska Native Medical Center, Anchorage, Alaska, USA
    Semin Liver Dis 25:3-8. 2005
    ..Persons identified with chronic HBV infection need lifelong, regular monitoring for the development of active liver disease and HCC...
  2. ncbi request reprint The natural history of chronic hepatitis B virus infection
    Brian J McMahon
    Viral Hepatitis Program, Alaska Native Medical Center, Anchorage, Alaska 99508 5902, USA
    Semin Liver Dis 24:17-21. 2004
    ..Future research will help clarify the outcome of chronic HBV infection...
  3. ncbi request reprint Reinfection after successful eradication of Helicobacter pylori: a 2-year prospective study in Alaska Natives
    B J McMahon
    Department of Internal Medicine, Alaska Native Medical Center, Anchorage, USA
    Aliment Pharmacol Ther 23:1215-23. 2006
    ..Limited information exists regarding risk factors for reinfection after cure of Helicobacter pylori infection...
  4. ncbi request reprint Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study
    B J McMahon
    Departments of Internal Medicine and Surgery, Alaska Native Medical Center, Indian Health Service, Public Health Service, U S Department of Health and Human Services, Anchorage, Alaska, USA
    Hepatology 32:842-6. 2000
    ..024), respectively. Screening of HBsAg carriers with semiannual AFP was effective in detecting most HCC tumors at a resectable stage and significantly prolonged survival rates when compared with historical controls in this population...
  5. ncbi request reprint Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up
    Brian J McMahon
    Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, and the Alaska Native Medical Center, Anchorage, Alaska 99508, USA
    Ann Intern Med 142:333-41. 2005
    ..The duration of protection afforded by hepatitis B vaccination is unknown...
  6. pmc The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B
    Brian J McMahon
    Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium and Arctic Investigations Program, Centers for Disease Control and Prevention, 4315 Diplomacy Drive, Anchorage, AK, 99508, USA
    Hepatol Int 3:334-42. 2009
    ..Chronic infection with hepatitis B virus (HBV) is associated with a high lifetime risk of developing hepatocellular carcinoma (HCC) and cirrhosis of the liver...
  7. doi request reprint The natural history of chronic hepatitis B virus infection
    Brian J McMahon
    Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, AK 99508, USA
    Hepatology 49:S45-55. 2009
    ..Also, nested case-control studies assessing immunological and host genetic factors among persons with active and inactive disease phases, HCC, and cirrhosis could be conducted using these types of cohorts...
  8. doi request reprint Implementing evidenced-based practice guidelines for the management of chronic hepatitis B virus infection
    Brian J McMahon
    Liver Disease and Hepatitis Program, Alaska Native Medical Center, Anchorage, Alaska 99508, USA
    Am J Med 121:S45-52. 2008
    ....
  9. pmc Natural history of chronic hepatitis B - clinical implications
    Brian J McMahon
    Liver Disease and Hepatitis Program, Alaska Native Medical Center, Anchorage, Alaska, USA
    Medscape J Med 10:91. 2008
  10. ncbi request reprint Viral hepatitis in the Arctic
    Brian J McMahon
    Viral Hepatitis Program, Alaska Native Medical Center Anchorage, Alaska 99508, USA
    Int J Circumpolar Health 63:41-8. 2004
    ..Summarize research on viral hepatitis in indigenous populations in the Arctic...
  11. ncbi request reprint Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose
    Brian J McMahon
    Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, Alaska, USA
    J Infect Dis 200:1390-6. 2009
    ..The duration of protection in children and adults (including health care workers) resulting from the hepatitis B vaccine primary series is unknown...
  12. doi request reprint Adverse outcomes in Alaska natives who recovered from or have chronic hepatitis C infection
    Brian J McMahon
    Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, 4315 Diplomacy Drive, Anchorage, Alaska 99508, USA
    Gastroenterology 138:922-31.e1. 2010
    ....
  13. doi request reprint Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program
    Brian J McMahon
    Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, AK 99508, USA
    Hepatology 54:801-7. 2011
    ....
  14. doi request reprint Natural history of chronic hepatitis B
    Brian J McMahon
    Alaska Native Tribal Health Consortium, Anchorage, AK, USA
    Clin Liver Dis 14:381-96. 2010
    ..Finally, ways in which the natural history can be altered by hepatitis B vaccination and identification, close monitoring, and appropriate treatment of chronically infected individuals are reviewed...
  15. ncbi request reprint The relationship among previous antimicrobial use, antimicrobial resistance, and treatment outcomes for Helicobacter pylori infections
    Brian J McMahon
    Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, and Alaska Native Medical Center, Anchorage, Alaska 99508, USA
    Ann Intern Med 139:463-9. 2003
    ..The relationship between previous antimicrobial treatments and infection with drug-resistant Helicobacter pylori is unknown...
  16. pmc Factors associated with the progression of fibrosis on liver biopsy in Alaska Native and American Indian persons with chronic hepatitis C
    Stephen E Livingston
    Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium Liver Disease and Hepatitis Program, Anchorage, Alaska 99508, USA
    Can J Gastroenterol 24:445-51. 2010
    ..Various factors influence the development and rate of fibrosis progression in chronic hepatitis C virus (HCV) infection...
  17. ncbi request reprint Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F
    Stephen E Livingston
    Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, Alaska
    Gastroenterology 133:1452-7. 2007
    ..Five hepatitis B virus genotypes were identified in Alaska Native persons; we analyzed clearance of HBeAg by age and genotype...
  18. doi request reprint Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus
    Josephine Simonetti
    Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, AK 99508, USA
    Hepatology 51:1531-7. 2010
    ..7 cases per 100,000 person-years of follow-up [95% CI 141.1-264.5; P < 0.001]). After loss of HBsAg, HBV DNA was detected in the sera of 28 (18%) of those who cleared a median of 3.6 years after clearance...
  19. ncbi request reprint Steatosis and hepatitis C in an Alaska Native/American Indian population
    Stephen E Livingston
    Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, Alaska 99508, USA
    Int J Circumpolar Health 65:253-60. 2006
    ..To determine the prevalence and characteristics of steatosis in Alaska Natives/American Indians (AN/AI) with chronic hepatitis C virus (HCV) infection...
  20. ncbi request reprint Alaska sentinel surveillance for antimicrobial resistance in Helicobacter pylori isolates from Alaska native persons, 1999-2003
    Michael G Bruce
    Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AK 99508, USA
    Helicobacter 11:581-8. 2006
    ..Previous studies in Alaska have demonstrated elevated proportions of antimicrobial resistance among Helicobacter pylori isolates...
  21. ncbi request reprint Results of a general hepatitis C lookback program for persons who received blood transfusions in a neonatal intensive care unit between January 1975 and July 1992
    Henry H Cagle
    Liver Disease and Hepatitis Program, Division of Community Health, Alaska Native Tribal Health Consortium, Anchorage 99508, USA
    Arch Pediatr Adolesc Med 161:125-30. 2007
    ..To notify persons who received a blood transfusion in a neonatal intensive care unit between January 1975 and July 1992 of their risk for hepatitis C infection and to encourage them to seek hepatitis C antibody testing...
  22. pmc Diagnostic accuracy of tests for Helicobacter pylori in an Alaska Native population
    Dana L Bruden
    Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging Zoonoses and Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AK 99508, United States
    World J Gastroenterol 17:4682-8. 2011
    ..High rates of Helicobacter pylori (H. pylori) infection, H. pylori treatment failure, and gastric cancer in this population necessitate documentation of infection status at multiple time points over a patient's life...
  23. ncbi request reprint Hepatitis C infection in Alaska Natives with persistently normal, persistently elevated or fluctuating alanine aminotransferase levels
    Michael G Bruce
    Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska
    Liver Int 26:643-9. 2006
    ....
  24. ncbi request reprint Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F
    Stephen E Livingston
    Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, AK 99508, USA
    J Infect Dis 195:5-11. 2007
    ..The development of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B virus (HBV) infection has been associated with specific HBV genotypes and the presence of specific mutations...
  25. ncbi request reprint Persistence of antibody to hepatitis B and protection from disease among Alaska natives immunized at birth
    Catherine M Dentinger
    Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AK, USA
    Pediatr Infect Dis J 24:786-92. 2005
    ..Alaska Native (AN) children were at high risk of acquiring hepatitis B virus (HBV) infection before vaccination began in 1983. We evaluated the long-term protection from hepatitis B (HB) vaccination among AN children immunized when infants...
  26. ncbi request reprint Epidemiology and risk factors for hepatitis C in Alaska Natives
    Brian J McMahon
    Viral Hepatitis Program, Alaska Native Medical Center, Anchorage, AK, USA
    Hepatology 39:325-32. 2004
    ..S. population. Persons with a history of blood transfusion were more likely to be HCV RNA positive than those without such history. Higher RNA levels found in males may explain the more severe disease previously reported in this group...
  27. doi request reprint Duration of protection against hepatitis A for the current two-dose vaccine compared to a three-dose vaccine schedule in children
    Gregory A Raczniak
    Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 4055 Tudor Centre Drive, Anchorage, AK 99508, USA
    Vaccine 31:2152-5. 2013
    ..The hepatitis A vaccine is highly effective but the duration of protection is unknown...
  28. ncbi request reprint Hepatitis B-associated vasculitis in Alaska Natives: viral genotype, clinical and serologic outcome
    Kathy J Hurlburt
    Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, AK 99508, USA
    Liver Int 27:627-32. 2007
    ....
  29. ncbi request reprint Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy
    Taraz Samandari
    Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Pediatrics 120:e373-81. 2007
    ..The duration of protection provided by hepatitis B vaccination is unknown, but the presence of immune memory can be evaluated indirectly by measuring the immune response to a booster dose of vaccine...
  30. doi request reprint Persistence of antibody to hepatitis A virus 10 years after vaccination among children and adults
    Laura L Hammitt
    Arctic Investigations Program, National Center for Preparedness, Detection and Control of Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    J Infect Dis 198:1776-82. 2008
    ..Hepatitis A vaccination is effective in preventing disease. However, the duration of protection after vaccination is unknown...
  31. ncbi request reprint Duration of hepatitis B immunity in low risk children receiving hepatitis B vaccinations from birth
    Kenneth M Petersen
    Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Alaska Native Tribal Health Consortium, Anchorage, AK 99508, USA
    Pediatr Infect Dis J 23:650-5. 2004
    ..The duration of protection after hepatitis B vaccination of infants is unknown...
  32. doi request reprint Chronic hepatitis B virus infection
    Brian J McMahon
    Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, 4315 Diplomacy Drive, Anchorage, AK 99508, USA Electronic address
    Med Clin North Am 98:39-54. 2014
    ..They should be used in those patients who meet the criteria outlined in the practice guidelines of the major liver societies...
  33. pmc Long-term immunogenicity of hepatitis A virus vaccine in Alaska 17 years after initial childhood series
    Gregory A Raczniak
    Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    J Infect Dis 207:493-6. 2013
    ..We report HAV antibody concentrations 17 years after childhood immunization, demonstrating that protective antibody levels remain and have stabilized over the past 7 years...
  34. pmc Treatment eligibility in Alaska Native and American Indian persons with hepatitis C virus infection
    Stephen E Livingston
    Alaska Native Tribal Health Consortium, Liver Disease and Hepatitis Program, Anchorage, AK 99508, USA
    Int J Circumpolar Health 71:1-7. 2012
    ..We examined treatment eligibility in a cohort of Alaska Native and American Indian persons with chronic HCV infection...
  35. pmc Evaluation of seaFAST, a rapid fluorescent in situ hybridization test, for detection of Helicobacter pylori and resistance to clarithromycin in paraffin-embedded biopsy sections
    Julie M Morris
    Arctic Investigations Program, CDC, 4055 Tudor Centre Drive, Anchorage, AK 99508, USA
    J Clin Microbiol 43:3494-6. 2005
    ..The FISH method was found to be 97% sensitive, 94% specific for the detection of H. pylori and comparable to agar dilution for the detection of resistance to clarithromycin...
  36. ncbi request reprint Results of a hepatitis C general transfusion lookback program for patients who received blood products before July 1992
    James L Williams
    Liver Disease and Hepatitis Program and the Community Health Aide Program, Division of Community Health Services, Alaska Native Tribal Health Consortium, Anchorage, Alaska 99508, USA
    Transfusion 45:1020-6. 2005
    ..A general transfusion lookback program was implemented to identify, counsel, and screen persons who received transfusions at the Alaska Native Medical Center between January 1980 and July 1992...
  37. pmc Dynamics of Helicobacter pylori-specific immunoglobulin G for 2 years after successful eradication of Helicobacter pylori infection in an American Indian and Alaska Native population
    Karen M Miernyk
    Alaska Native Tribal Health Consortium, Arctic Investigations Program, Centers for Disease Control and Prevention, 4055 Tudor Centre Dr, Anchorage, AK 99508, USA
    Clin Vaccine Immunol 14:85-6. 2007
    ..Two months after treatment, 82% of H. pylori-negative persons remained seropositive. While there were declines in H. pylori antibodies for 12 months, after 24 months 71% of persons remained seropositive...
  38. ncbi request reprint The relationship between previous fluoroquinolone use and levofloxacin resistance in Helicobacter pylori infection
    John J Carothers
    Native Medical Center, Anchorage, Alaska, USA
    Clin Infect Dis 44:e5-8. 2007
    ..pylori isolates that were resistant to levofloxacin. Levofloxacin resistance was associated with any prior fluoroquinolone use over the previous 10 years and with the total number of fluoroquinolone courses prescribed (P<.001)...
  39. ncbi request reprint Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years
    Laura L Hammitt
    Arctic Investigations Program, Centers for Disease Control and Prevention, Anchorage, AK, USA
    Vaccine 25:6958-64. 2007
    ..These children had protective anti-HBs concentrations when tested after receiving a three-dose series of 2.5 microg recombinant hepatitis B vaccine starting at birth...
  40. doi request reprint Persistence of hepatitis A vaccine induced seropositivity in infants and young children by maternal antibody status: 10-year follow-up
    Umid M Sharapov
    Division of Viral Hepatitis, National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Hepatology 56:516-22. 2012
    ..Anti-HAV levels through 10 years of age correlated with initial peak anti-HAV levels (tested at 1 month after the second dose)...
  41. doi request reprint Chronic liver disease among Alaska-Native people, 2003-2004
    Gayle E Fischer
    Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Am J Gastroenterol 104:363-70. 2009
    ..The objectives of this study were to determine CLD prevalence and to define its etiologies and complications among AN and AI people, who received health care from an urban hospital center...
  42. ncbi request reprint A prospective evaluation of 200 upper endoscopies performed in Alaska Native persons
    Frank Sacco
    Department of Surgery, Alaska Native Medical Center, Anchorage 99508, USA
    Int J Circumpolar Health 66:144-52. 2007
    ..To characterize the nature and prevalence of disease in Alaska Native patients referred for evaluation of upper gastrointestinal signs and symptoms...
  43. ncbi request reprint Immunogenicity of an inactivated hepatitis A vaccine in infants and young children
    Beth P Bell
    Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Pediatr Infect Dis J 26:116-22. 2007
    ..We compared HA vaccine immunogenicity among infants born to immune and susceptible mothers, vaccinated on different schedules...
  44. ncbi request reprint Estimating the date of hepatitis C virus infection from patient interviews and antibody tests on stored sera
    Dana L Bruden
    Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska 99508, USA
    Am J Gastroenterol 99:1517-22. 2004
    ..The date of HCV infection is often estimated using the year of a pre-1992 blood transfusion (BT), or the first year of injecting drug use (IDU). We sought to determine the accuracy of these dates obtained by interview...
  45. ncbi request reprint Hepatitis A vaccine: immunogenicity following administration of a delayed immunization schedule in infants, children and adults
    James L Williams
    Viral Hepatitis Program, Alaska Native Medical Center, ANC HEP, 4315 Diplomacy Drive, 99508, Anchorage, AK, USA
    Vaccine 21:3208-11. 2003
    ..Findings suggest a booster administered 20-31 months after the primary dose is immunogenic and GMT in persons >2 years of age were comparable to those seen in adults and children who receive hepatitis A vaccine per schedule...
  46. ncbi request reprint Mortality caused by chronic liver disease among American Indians and Alaska Natives in the United States, 1999-2009
    Anil Suryaprasad
    Anil Suryaprasad and Kathy K Byrd are with the Division of Viral Hepatitis National Center for HIV AIDS, Viral Hepatitis, STD, and TB Prevention Centers for Disease Control and Prevention CDC US Department of Health and Human Services Atlanta, GA John T Redd is with the Santa Fe Public Health Service Indian Hospital, Indian Health Service, US Department of Health and Human Services, Santa Fe, NM David G Perdue is with the American Indian Cancer Foundation and Minnesota Gastroenterology PA, Minneapolis M Michele Manos is with the Kaiser Permanente Division of Research, Oakland, CA Brian J McMahon is with the Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AL
    Am J Public Health 104:S350-8. 2014
    ..We compared chronic liver disease (CLD) mortality from 1999 to 2009 between American Indians and Alaska Natives (AI/ANs) and Whites in the United States after improving CLD case ascertainment and AI/AN race classification...
  47. doi request reprint Impact of a statewide childhood vaccine program in controlling hepatitis A virus infections in Alaska
    Rosalyn J Singleton
    Arctic Investigations Program, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention CDC, Anchorage, AK 99508, USA
    Vaccine 28:6298-304. 2010
    ..3) in 2002-2007 was lower than the overall U.S. 2007 rate (1.0). Among age groups, the decrease (99.8%) among children aged 0-14 years was the largest. Routine childhood vaccination has nearly eliminated HAV infection in Alaska...
  48. ncbi request reprint Impact of recurrent epidemics of hepatitis a virus infection on population immunity levels: Bristol Bay, Alaska
    Dolly Peach
    Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 4055 Tudor Centre Drive, Anchorage, AK 99508, USA
    J Infect Dis 186:1081-5. 2002
    ..Little transmission occurred between epidemics. Vaccination of children against HAV should prevent future epidemics...
  49. doi request reprint Relationship between level of hepatitis B virus DNA and liver disease: a population-based study of hepatitis B e antigen-negative persons with hepatitis B
    Brian J McMahon
    Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, Alaska Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention CDC, Anchorage, Alaska
    Clin Gastroenterol Hepatol 12:701-6.e1-3. 2014
    ....
  50. doi request reprint Internist diagnosis and management of chronic hepatitis B virus infection
    Brian J McMahon
    Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Alaska Native Medical Center, Anchorage, Alaska, USA
    Am J Med 125:1063-7. 2012
    ..Internal medicine specialists, including primary care providers and subspecialists, need to understand the steps they can take to address this often under-recognized disorder...
  51. ncbi request reprint Selecting appropriate management strategies for chronic hepatitis B: who to treat
    Brian J McMahon
    Alaska Native Medical Center, 4315 Diplomacy Drive, Anchorage, AK 99508, USA
    Am J Gastroenterol 101:S7-12. 2006
    ..Hepatitis B virus (HBV) infection is a significant problem. In the United States estimates indicate that 0.3% of the population (1.25 million individuals) have chronic hepatitis B infection...
  52. pmc Azathioprine metabolite measurements are not useful in following treatment of autoimmune hepatitis in Alaska Native and other non-Caucasian people
    Elizabeth D Ferucci
    Alaska Native Tribal Health Consortium, Anchorage, Alaska 99508, USA
    Can J Gastroenterol 25:21-7. 2011
    ..In autoimmune hepatitis (AIH) patients treated with azathioprine, the utility of measuring thiopurine methyltransferase (TPMT) and azathioprine metabolites has been limited...
  53. doi request reprint Impact of immunizations on the disease burden of American Indian and Alaska native children
    Rosalyn Singleton
    Alaska Native Tribal Consortium, Arctic Investigations Program, National Center for Preparedness, Detection, and Control of Infectious Diseases, Centers for Disease Control and Prevention, 4055 Tudor Centre Dr, Anchorage, Alaska 99508, USA
    Arch Pediatr Adolesc Med 163:446-53. 2009
    ..Although tremendous strides have been made in eliminating disparities in infectious disease among AI/AN children, further gains will require addressing disparities in adverse living conditions...
  54. ncbi request reprint Prevalence of autoimmune liver disease in Alaska Natives
    Kathy J Hurlburt
    Viral Hepatitis Program, Alaska Native Medical Center, Anchorage 99508, USA
    Am J Gastroenterol 97:2402-7. 2002
    ..There is limited information on the prevalence of autoimmune liver disease in nonwhite populations. We conducted a population-based study on the prevalence of autoimmune liver diseases in Alaska natives...
  55. ncbi request reprint Hepatitis C virus dynamics during natural infection are associated with long-term histological outcome of chronic hepatitis C disease
    Daniel G Sullivan
    University of Washington School of Medicine, Seattle, WA, USA
    J Infect Dis 196:239-48. 2007
    ..The long-term dynamics of hepatitis C virus (HCV) infection and their association with hepatitis C disease are unknown...
  56. ncbi request reprint High rate of spontaneous negativity for hepatitis C virus RNA after establishment of chronic infection in Alaska Natives
    John D Scott
    Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA
    Clin Infect Dis 42:945-52. 2006
    ..Hepatitis C virus (HCV) leads to chronic infection in 70%-85% of exposed patients. Spontaneous clearance of the virus after chronic infection is believed to occur rarely...
  57. ncbi request reprint Viral hepatitis in the Arctic. A review from a Circumpolar Workshop on Viral hepatitis, ICCH13
    Andrei Tulisov
    Northern State Medical University, Arkhangelsk, Russia
    Alaska Med 49:193-203. 2007
    ....
  58. ncbi request reprint Classification of hepatitis B virus genotype B into 2 major types based on characterization of a novel subgenotype in Arctic indigenous populations
    Tomoyuki Sakamoto
    Department of Clinical Molecular Informative Medicine, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
    J Infect Dis 196:1487-92. 2007
    ..The results suggest that HBV/B may be classified into nonrecombinant (Bj/B1 and B6) and recombinant (Ba/B2-B5) types...
  59. pmc Investigation of putative multisubtype hepatitis C virus infections in vivo by heteroduplex mobility analysis of core/envelope subgenomes
    Hui Li
    Department of Laboratory Medicine, University of Washington Medical Center, Seattle, Washington, USA
    J Virol 82:7524-32. 2008
    ..In summary, a large proportion of mixed-genotype and switching-genotype patterns generated by 5'-UTR analysis were not reproducible using the HMA approach, emphasizing the need for additional study...
  60. pmc Hepatitis C virus envelope glycoprotein co-evolutionary dynamics during chronic hepatitis C
    Hui Li
    Department of Laboratory Medicine, University of Washington Medical Center, Seattle, WA, USA
    Virology 375:580-91. 2008
    ..44 versus r=0.17, respectively; P=0.01). In summary, HCV envelope quasispecies co-evolution differs during mild versus severe disease...
  61. ncbi request reprint [AASLD Practice Guidelines. Chronic hepatitis B: update of therapeutic guidelines]
    Anna S F Lok
    Rom J Gastroenterol 13:150-4. 2004
  62. ncbi request reprint Chronic hepatitis B: update of recommendations
    Anna S F Lok
    Division of Gastroenterology, University of Michigan Medical Center, 3912 Taubman Center, Ann Arbor, MI 48109 0362, USA
    Hepatology 39:857-61. 2004
  63. ncbi request reprint Chronic hepatitis B
    Anna S F Lok
    Division of Gastroenterology, University of Michigan Medical Center, 3912 Taubman Center, Box 0362, Ann Arbor, MI 48109 0362, USA
    Hepatology 45:507-39. 2007